Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
469,894
-
Shares change
-
+469,894
-
Total reported value, excl. options
-
$2,170,000
-
Value change
-
+$2,170,000
-
Number of buys
-
12
-
Price
-
$4.63
Significant Holders of LISATA THERAPEUTICS, INC. - COM (LSTA) as of Q3 2022
13 filings reported holding LSTA - LISATA THERAPEUTICS, INC. - COM as of Q3 2022.
LISATA THERAPEUTICS, INC. - COM (LSTA) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 469,894 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (176,305 shares), RENAISSANCE TECHNOLOGIES LLC (100,922 shares), SABBY MANAGEMENT, LLC (63,508 shares), BlackRock Inc. (56,807 shares), GEODE CAPITAL MANAGEMENT, LLC (26,038 shares), STATE STREET CORP (14,349 shares), DIMENSIONAL FUND ADVISORS LP (12,333 shares), COOK WEALTH MANAGEMENT GROUP LLC (12,175 shares), UBS Group AG (4,687 shares), and MORGAN STANLEY (1,242 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.